Assessment of Symptoms Control, Pulmonary Function and Related Quality of Life in Asthmatic Patients Treated with Extrafine Beclomethasone Dipropionate/Formoterol Fumarate 100/6 &mu;g pMDI: Results of a Multicenter Observational Study in Romania (ALFRESCO Study)

Original Research

Assessment of Symptoms Control, Pulmonary Function and Related Quality of Life in Asthmatic Patients Treated with Extrafine Beclomethasone Dipropionate/Formoterol Fumarate 100/6 μg pMDI: Results of a Multicenter Observational Study in Romania (ALFRESCO Study)

Total article views		HTML views	PDF downloads	Totals
5,344	Dovepress*	5,048+	209	5,257
	PubMed Central*	296	125	421
	Totals	5,344	334	5,678
*Since 8 July 2022